PhD Studentships

The Centre offers a number of four-year PhD studentships, funded by Cancer Research UK, that are designed to give students an opportunity to complete a PhD in one of its wide range of excellent research labs. These provide students with a generous stipend of £19,000 per year (to cover their living expenses) plus their university matriculation fees and some lab running expenses. Studentships are open to graduates with a very good degree in a life sciences subject, who have an aptitude for experimental work. Studentships typically start in October each year with the call for applications opening in October/November of the preceding year.

Applications are invited from outstanding candidates to join a Cancer Research UK funded PhD programme at the Edinburgh Cancer Research Centre, CRUK Beatson Institute and the Institute of Cancer Sciences, University of Glasgow. These are funded by the Cancer Research UK Scotland Centre, a joint initiative between Edinburgh and Glasgow which brings together cancer scientists and clinicians from across the Universities of Edinburgh and Glasgow, delivering outstanding cancer research and improved patient care. The Cancer Research UK PhD programme is integrated into the research activities of the Centre with over 80 principal investigators contributing to this cross-disciplinary programme spanning from fundamental science to translational research. Research projects benefit from state-of-the art facilities for genomics, mass spectrometry, advanced microscopy, single cell technologies, and from advanced computational and informatics capabilities.

Application procedure

Up to 3 studentships are available to start in September 2022 for outstanding applicants with a stipend of £19,000 p/a. These are funded by the CRUK Scotland Centre, a joint initiative between Edinburgh and Glasgow. Successful students will be registered for their degree in either Glasgow or Edinburgh, depending on the project they apply for.

We are looking for students with a very good degree in a Life Sciences subject and an aptitude for experimental work, who are also highly committed to pursuing a PhD and a career in cancer research. You should hold at least an upper second-class degree in a relevant subject and comply with English language requirements.

All applications will be administered centrally via the University of Edinburgh, please apply on the link below – this includes Glasgow-based projects with Glasgow-based supervisors:

Closing date: 27 May 2022

Interviews are expected to be held week beginning 27 June.

Applications are open to all individuals irrespective of nationality or country of residence.

A multimodal deep learning model to predict individual cancer patient survival probabilities

Dr Peter Hall, Dr Colin McLean, Professor Joanne Edwards

Preclinical investigation of novel super-selective mTOR inhibitors in colorectal cancer

Dr Asier Unciti-Broceta, Professor Owen Sansom, Professor Margaret Frame

Targeting Integrin Linked kinase (ILK) in Glioblastoma

Professor Neil Carragher, Dr Joanna Birch, Professor Margaret Frame

The role of dynamic changes in proteome in pancreatic cancer initiation

Dr Simon Wilkinson, Professor Jennifer Morton, Professor Sara Zanivan

Differential growth factor pathways in mesothelioma subtypes

Prof Daniel J. Murphy and Dr Luke Boulter

Exploiting metabolic vulnerabilities induced by dietary restriction as novel therapies for infant leukaemia

Professor Christina Halsey and Professor Katrin Ottersbach

Professor Christina Halsey and Professor Katrin Ottersbach

Understanding the pro- and anti-tumour functions of IFNγ-producing γδ T cells

Dr Seth Coffelt and Dr Kevin Myant

Elucidating the role of primary and secondary senescence in liver cancer

Dr Kristina Kirschner, Dr Tom Bird, Professor Stuart Forbes

Understanding the role of IKKa in the tumour microenvironment and establishing it as a novel therapeutic target in colorectal cancer

Professor Joanne Edwards, Dr Lesley Stark, Dr Nigel Jamieson

Development of cellular and tissue segmentation algorithms within the digital pathology platform QuPath for accurate assessment of mIF across a breadth of solid tumours.

Professor John Le Quesne, Dr Peter Bankhead, Professor Joanne Edwards

Investigating the Role of Tertiary Lymphoid Structures in Tumour-Mediated Immunosuppression in pancreaticobiliary cancer employing spatial biology characterisation.

Dr Nigel Jamieson, Dr Peter Bankhead, Professor John Le Quesne

Dissecting the role of Activin signalling in Pancreatic Ductal Adenocarcinoma

Professor Jennifer Morton, Dr Alan Serrels, Professor Gareth Inman